-+ 0.00%
-+ 0.00%
-+ 0.00%

Tigermed plans to sell Frontage's overseas laboratory business to Charles River, Song Li

PUBT·11/10/2026 09:53:59
Listen to the news
Tigermed plans to sell Frontage's overseas laboratory business to Charles River, Song Li
  • Tigermed proposes to participate in the privatization of controlled subsidiary Frontage Holdings through wholly owned Hongkong Tigermed.
  • Subsequent restructuring would sell Frontage's overseas laboratory services business to Charles River Laboratories, Frontage Chairman Song Li and his trusts.
  • Frontage's China business would be retained, supporting a sharper focus on clinical contract research services and more efficient resource allocation.
  • The transactions are expected to generate proceeds and investment gains for Tigermed, which acquired control of Frontage in 2014.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hangzhou Tigermed Consulting Co. Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: CN93812) on November 10, 2026, and is solely responsible for the information contained therein.